{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:31:11Z","timestamp":1793316671118,"version":"4.5.0"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41582-025-01153-z","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:10:45Z","timestamp":1761318645000},"page":"706-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fatigue: a common but poorly understood symptom in neurological and non-neurological diseases"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-1034","authenticated-orcid":false,"given":"Iris-Katharina","family":"Penner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"1153_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","volume":"80","author":"BM Kluger","year":"2013","unstructured":"Kluger, B. M., Krupp, L. B. & Enoka, R. M. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80, 409\u2013416 (2013).","journal-title":"Neurology"},{"key":"1153_CR2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1152\/physrev.2001.81.4.1725","volume":"81","author":"SC Gandevia","year":"2001","unstructured":"Gandevia, S. C. Spinal and supraspinal factors in human muscle fatigue. Physiol. Rev. 81, 1725\u20131789 (2001).","journal-title":"Physiol. Rev."},{"key":"1153_CR3","unstructured":"Spielberger, C. D., Gorsuch, R. L. & Lushene, R. E. STAI Manual for the State-trait Anxiety Inventory (\u201cSelf-evaluation Questionnaire\u201d) (Consulting Psychologists Press, 1970)."},{"key":"1153_CR4","doi-asserted-by":"publisher","first-page":"790006","DOI":"10.3389\/fnhum.2022.790006","volume":"16","author":"GR Wylie","year":"2022","unstructured":"Wylie, G. R., Pra Sisto, A. J., Genova, H. M. & DeLuca, J. Fatigue across the lifespan in men and women: state vs. trait. Front. Hum. Neurosci. 16, 790006 (2022).","journal-title":"Front. Hum. Neurosci."},{"key":"1153_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp, L. B., LaRocca, N. G., Muir-Nash, J. & Steinberg, A. D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 46, 1121\u20131123 (1989).","journal-title":"Arch. Neurol."},{"key":"1153_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1023\/A:1008960710415","volume":"9","author":"L Kleinman","year":"2000","unstructured":"Kleinman, L. et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual. Life Res. 9, 499\u2013508 (2000).","journal-title":"Qual. Life Res."},{"key":"1153_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00296-010-1558-3","volume":"32","author":"A Gencay-Can","year":"2012","unstructured":"Gencay-Can, A. & Can, S. S. Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatol. Int. 32, 27\u201331 (2012).","journal-title":"Rheumatol. Int."},{"key":"1153_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101874","volume":"58","author":"J Heine","year":"2023","unstructured":"Heine, J. et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. EClinicalMedicine 58, 101874 (2023).","journal-title":"EClinicalMedicine"},{"key":"1153_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner, I. K. et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult. Scler. 15, 1509\u20131517 (2009).","journal-title":"Mult. Scler."},{"key":"1153_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S0317167100048691","volume":"21","author":"JD Fisk","year":"1994","unstructured":"Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J. & Murray, T. J. The impact of fatigue on patients with multiple sclerosis. Can. J. Neurol. Sci. 21, 9\u201314 (1994).","journal-title":"Can. J. Neurol. Sci."},{"key":"1153_CR11","unstructured":"Multiple Sclerosis Clinical Practice Guidelines. Fatigue and Multiple Sclerosis: Evidence-based Management Strategies for Fatigue in Multiple Sclerosis (Paralyzed Veterans of America, 1998)."},{"key":"1153_CR12","doi-asserted-by":"crossref","unstructured":"Flachenecker, P. et al. \u201cFatigue\u201d in multiple sclerosis. Development and and validation of the \u201cWurzburger Fatigue Inventory for MS\u201d. Nervenarzt 77, 165\u2013166, 168-170, 172-164 (2006).","DOI":"10.1007\/s00115-005-1990-x"},{"key":"1153_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"T Chalder","year":"1993","unstructured":"Chalder, T. et al. Development of a fatigue scale. J. Psychosom. Res. 37, 147\u2013153 (1993).","journal-title":"J. Psychosom. Res."},{"key":"1153_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.06.017","volume":"100","author":"BD Loy","year":"2017","unstructured":"Loy, B. D., Taylor, R. L., Fling, B. W. & Horak, F. B. Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: a systematic review and meta-analysis. J. Psychosom. Res. 100, 1\u20137 (2017).","journal-title":"J. Psychosom. Res."},{"key":"1153_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12984-020-00798-9","volume":"17","author":"AA Ibrahim","year":"2020","unstructured":"Ibrahim, A. A. et al. Inertial sensor-based gait parameters reflect patient-reported fatigue in multiple sclerosis. J. Neuroeng. Rehabil. 17, 165 (2020).","journal-title":"J. Neuroeng. Rehabil."},{"key":"1153_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.gaitpost.2015.12.014","volume":"44","author":"A Kalron","year":"2016","unstructured":"Kalron, A. The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis. Gait Posture 44, 178\u2013183 (2016).","journal-title":"Gait Posture"},{"key":"1153_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0997-9","volume":"19","author":"ML Frechette","year":"2019","unstructured":"Frechette, M. L. et al. Next steps in wearable technology and community ambulation in multiple sclerosis. Curr. Neurol. Neurosci. Rep. 19, 80 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1153_CR18","doi-asserted-by":"publisher","first-page":"1231321","DOI":"10.3389\/fnins.2023.1231321","volume":"17","author":"C Pinarello","year":"2023","unstructured":"Pinarello, C., Elmers, J., Inojosa, H., Beste, C. & Ziemssen, T. Management of multiple sclerosis fatigue in the digital age: from assessment to treatment. Front. Neurosci. 17, 1231321 (2023).","journal-title":"Front. Neurosci."},{"key":"1153_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.23736\/S1973-9087.19.05878-7","volume":"56","author":"F Van Geel","year":"2020","unstructured":"Van Geel, F., Moumdjian, L., Lamers, I., Bielen, H. & Feys, P. Measuring walking-related performance fatigability in clinical practice: a systematic review. Eur. J. Phys. Rehabil. Med. 56, 88\u2013103 (2020).","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"1153_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00421-019-04264-w","volume":"120","author":"E Ce","year":"2020","unstructured":"Ce, E. et al. Peripheral fatigue: new mechanistic insights from recent technologies. Eur. J. Appl. Physiol. 120, 17\u201339 (2020).","journal-title":"Eur. J. Appl. Physiol."},{"key":"1153_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cnp.2023.12.004","volume":"9","author":"H Tankisi","year":"2024","unstructured":"Tankisi, H., Versace, V., Kuppuswamy, A. & Cole, J. The role of clinical neurophysiology in the definition and assessment of fatigue and fatigability. Clin. Neurophysiol. Pract. 9, 39\u201350 (2024).","journal-title":"Clin. Neurophysiol. Pract."},{"key":"1153_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13533","volume":"231","author":"CG Brownstein","year":"2021","unstructured":"Brownstein, C. G., Millet, G. Y. & Thomas, K. Neuromuscular responses to fatiguing locomotor exercise. Acta Physiol. 231, e13533 (2021).","journal-title":"Acta Physiol."},{"key":"1153_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1073858420985447","volume":"28","author":"A Kuppuswamy","year":"2022","unstructured":"Kuppuswamy, A. The neurobiology of pathological fatigue: new models, new questions. Neuroscientist 28, 238\u2013253 (2022).","journal-title":"Neuroscientist"},{"key":"1153_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1152\/jn.00514.2021","volume":"128","author":"EJ Brotherton","year":"2022","unstructured":"Brotherton, E. J., Sabapathy, S., McKeown, D. J. & Kavanagh, J. J. People with multiple sclerosis have reduced TMS-evoked motor cortical output compared with healthy individuals during fatiguing submaximal contractions. J. Neurophysiol. 128, 105\u2013117 (2022).","journal-title":"J. Neurophysiol."},{"key":"1153_CR25","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1249\/MSS.0000000000003233","volume":"55","author":"N Royer","year":"2023","unstructured":"Royer, N. et al. A comprehensive evaluation of multiple sclerosis-related fatigue with a special focus on fatigability. Med. Sci. Sports Exerc. 55, 2002\u20132013 (2023).","journal-title":"Med. Sci. Sports Exerc."},{"key":"1153_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/mus.880170702","volume":"17","author":"JP Brasil-Neto","year":"1994","unstructured":"Brasil-Neto, J. P., Cohen, L. G. & Hallett, M. Central fatigue as revealed by postexercise decrement of motor evoked potentials. Muscle Nerve 17, 713\u2013719 (1994).","journal-title":"Muscle Nerve"},{"key":"1153_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/mus.20739","volume":"36","author":"MP Garssen","year":"2007","unstructured":"Garssen, M. P., Schillings, M. L., Van Doorn, P. A., Van Engelen, B. G. & Zwarts, M. J. Contribution of central and peripheral factors to residual fatigue in Guillain\u2013Barre syndrome. Muscle Nerve 36, 93\u201399 (2007).","journal-title":"Muscle Nerve"},{"key":"1153_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1152\/japplphysiol.01053.2007","volume":"104","author":"JL Taylor","year":"2008","unstructured":"Taylor, J. L. & Gandevia, S. C. A comparison of central aspects of fatigue in submaximal and maximal voluntary contractions. J. Appl. Physiol. 104, 542\u2013550 (2008).","journal-title":"J. Appl. Physiol."},{"key":"1153_CR29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1152\/japplphysiol.00775.2016","volume":"122","author":"TJ Carroll","year":"2017","unstructured":"Carroll, T. J., Taylor, J. L. & Gandevia, S. C. Recovery of central and peripheral neuromuscular fatigue after exercise. J. Appl. Physiol. 122, 1068\u20131076 (2017).","journal-title":"J. Appl. Physiol."},{"key":"1153_CR30","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1249\/MSS.0000000000000923","volume":"48","author":"JL Taylor","year":"2016","unstructured":"Taylor, J. L., Amann, M., Duchateau, J., Meeusen, R. & Rice, C. L. Neural contributions to muscle fatigue: from the brain to the muscle and back again. Med. Sci. Sports Exerc. 48, 2294\u20132306 (2016).","journal-title":"Med. Sci. Sports Exerc."},{"key":"1153_CR31","doi-asserted-by":"publisher","first-page":"779069","DOI":"10.3389\/fnrgo.2021.779069","volume":"2","author":"O Tyagi","year":"2021","unstructured":"Tyagi, O. & Mehta, R. K. A methodological framework to capture neuromuscular fatigue mechanisms under stress. Front. Neuroergon. 2, 779069 (2021).","journal-title":"Front. Neuroergon."},{"key":"1153_CR32","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1113\/JP282564","volume":"600","author":"M Amann","year":"2022","unstructured":"Amann, M., Sidhu, S. K., McNeil, C. J. & Gandevia, S. C. Critical considerations of the contribution of the corticomotoneuronal pathway to central fatigue. J. Physiol. 600, 5203\u20135214 (2022).","journal-title":"J. Physiol."},{"key":"1153_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00421-017-3788-5","volume":"118","author":"J Rodriguez-Falces","year":"2018","unstructured":"Rodriguez-Falces, J. & Place, N. Determinants, analysis and interpretation of the muscle compound action potential (M wave) in humans: implications for the study of muscle fatigue. Eur. J. Appl. Physiol. 118, 501\u2013521 (2018).","journal-title":"Eur. J. Appl. Physiol."},{"key":"1153_CR34","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.3390\/ijms222111587","volume":"22","author":"D Constantin-Teodosiu","year":"2021","unstructured":"Constantin-Teodosiu, D. & Constantin, D. Molecular mechanisms of muscle fatigue. Int. J. Mol. Sci. 22, 11587 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1153_CR35","doi-asserted-by":"publisher","first-page":"103215","DOI":"10.1016\/j.msard.2021.103215","volume":"56","author":"C Dettmers","year":"2021","unstructured":"Dettmers, C., Marchione, S., Weimer-Jaekel, A., Godde, B. & Joebges, M. Cognitive fatigability, not fatigue predicts employment status in patients with MS three months after rehabilitation. Mult. Scler. Relat. Disord. 56, 103215 (2021).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1153_CR36","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1177\/1352458510374202","volume":"16","author":"N Weinges-Evers","year":"2010","unstructured":"Weinges-Evers, N. et al. Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult. Scler. 16, 1134\u20131140 (2010).","journal-title":"Mult. Scler."},{"key":"1153_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/09602011.2012.726925","volume":"23","author":"D Claros-Salinas","year":"2013","unstructured":"Claros-Salinas, D. et al. Induction of cognitive fatigue in MS patients through cognitive and physical load. Neuropsychol. Rehabil. 23, 182\u2013201 (2013).","journal-title":"Neuropsychol. Rehabil."},{"key":"1153_CR38","doi-asserted-by":"crossref","first-page":"205520762211177","DOI":"10.1177\/20552076221117740","volume":"8","author":"L Barrios","year":"2022","unstructured":"Barrios, L. et al. Cognitive fatigability assessment test (cFAST): development of a new instrument to assess cognitive fatigability and pilot study on its association to perceived fatigue in multiple sclerosis. Digit. Health 8, 20552076221117740 (2022).","journal-title":"Digit. Health"},{"key":"1153_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062463","volume":"12","author":"A Elb\u00e9ji","year":"2022","unstructured":"Elb\u00e9ji, A. et al. Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study. BMJ Open 12, e062463 (2022).","journal-title":"BMJ Open"},{"key":"1153_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1545968306298934","volume":"22","author":"D Kos","year":"2008","unstructured":"Kos, D., Kerckhofs, E., Nagels, G., D\u2019Hooghe, M. B. & Ilsbroukx, S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil. Neural Repair 22, 91\u2013100 (2008).","journal-title":"Neurorehabil. Neural Repair"},{"key":"1153_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuropsychologia.2018.04.030","volume":"123","author":"T Muller","year":"2019","unstructured":"Muller, T. & Apps, M. A. J. Motivational fatigue: a neurocognitive framework for the impact of effortful exertion on subsequent motivation. Neuropsychologia 123, 141\u2013151 (2019).","journal-title":"Neuropsychologia"},{"key":"1153_CR42","volume-title":"Professional manual. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI)","author":"PT Costa Jr","year":"1992","unstructured":"Costa, P. T. Jr, McCrae, R. R. Professional manual. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI)(Psychological Assessment Resources, 1992)."},{"key":"1153_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1467-6494.1992.tb00970.x","volume":"60","author":"RR McCrae","year":"1992","unstructured":"McCrae, R. R. & John, O. P. An introduction to the five-factor model and its applications. J. Pers. 60, 175\u2013215 (1992).","journal-title":"J. Pers."},{"key":"1153_CR44","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/mds.28575","volume":"36","author":"A Terracciano","year":"2021","unstructured":"Terracciano, A. et al. Neuroticism and risk of Parkinson\u2019s disease: a meta-analysis. Mov. Disord. 36, 1863\u20131870 (2021).","journal-title":"Mov. Disord."},{"key":"1153_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0022-3956(95)00040-2","volume":"30","author":"SK Johnson","year":"1996","unstructured":"Johnson, S. K., DeLuca, J. & Natelson, B. H. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. J. Psychiatr. Res. 30, 9\u201320 (1996).","journal-title":"J. Psychiatr. Res."},{"key":"1153_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0022-3999(02)00332-X","volume":"54","author":"SS Taillefer","year":"2003","unstructured":"Taillefer, S. S., Kirmayer, L. J., Robbins, J. M. & Lasry, J. C. Correlates of illness worry in chronic fatigue syndrome. J. Psychosom. Res. 54, 331\u2013337 (2003).","journal-title":"J. Psychosom. Res."},{"key":"1153_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1034\/j.1600-0404.2003.02037.x","volume":"107","author":"S Merkelbach","year":"2003","unstructured":"Merkelbach, S., Konig, J. & Sittinger, H. Personality traits in multiple sclerosis (MS) patients with and without fatigue experience. Acta Neurol. Scand. 107, 195\u2013201 (2003).","journal-title":"Acta Neurol. Scand."},{"key":"1153_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fneur.2015.00002","volume":"6","author":"H Schreiber","year":"2015","unstructured":"Schreiber, H., Lang, M., Kiltz, K. & Lang, C. Is personality profile a relevant determinant of fatigue in multiple sclerosis? Front. Neurol. 6, 2 (2015).","journal-title":"Front. Neurol."},{"key":"1153_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103707","volume":"111","author":"Y Ma","year":"2020","unstructured":"Ma, Y. et al. Prevalence and risk factors of cancer-related fatigue: a systematic review and meta-analysis. Int. J. Nurs. Stud. 111, 103707 (2020).","journal-title":"Int. J. Nurs. Stud."},{"key":"1153_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1037\/h0048837","volume":"64","author":"E Duffy","year":"1957","unstructured":"Duffy, E. The psychological significance of the concept of arousal or activation. Psychol. Rev. 64, 265\u2013275 (1957).","journal-title":"Psychol. Rev."},{"key":"1153_CR51","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/alz.12358","volume":"17","author":"DS Miller","year":"2021","unstructured":"Miller, D. S. et al. Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement. 17, 1892\u20131904 (2021).","journal-title":"Alzheimers Dement."},{"key":"1153_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169938","volume":"12","author":"YS Ang","year":"2017","unstructured":"Ang, Y. S., Lockwood, P., Apps, M. A., Muhammed, K. & Husain, M. Distinct subtypes of apathy revealed by the apathy motivation index. PLoS ONE 12, e0169938 (2017).","journal-title":"PLoS ONE"},{"key":"1153_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11071-5","volume":"12","author":"L Daumas","year":"2022","unstructured":"Daumas, L. et al. Associations, overlaps and dissociations between apathy and fatigue. Sci. Rep. 12, 7387 (2022).","journal-title":"Sci. Rep."},{"key":"1153_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ane.12651","volume":"134","author":"IK Penner","year":"2016","unstructured":"Penner, I. K. Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions. Acta Neurol. Scand. 134, 19\u201323 (2016).","journal-title":"Acta Neurol. Scand."},{"key":"1153_CR55","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983).","journal-title":"Neurology"},{"key":"1153_CR56","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt, G. et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult. Scler. 23, 1123\u20131136 (2017).","journal-title":"Mult. Scler."},{"key":"1153_CR57","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/1352458518769837","volume":"25","author":"G Kobelt","year":"2019","unstructured":"Kobelt, G., Langdon, D. & J\u00f6nsson, L. The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis. Mult. Scler. 25, 740\u2013749 (2019).","journal-title":"Mult. Scler."},{"key":"1153_CR58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert, P. et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol. 21, 246\u2013257 (2022).","journal-title":"Lancet Neurol."},{"key":"1153_CR59","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000885","volume":"7","author":"O Aktas","year":"2020","unstructured":"Aktas, O. et al. Serum neurofilament light chain: no clear relation to cognition and neuropsychiatric symptoms in stable MS. Neurol. Neuroimmunol. Neuroinflamm. 7, e885 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1153_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/1352458507082480","volume":"14","author":"P Flachenecker","year":"2008","unstructured":"Flachenecker, P. & Meissner, H. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment. Mult. Scler. 14, 274\u2013277 (2008).","journal-title":"Mult. Scler."},{"key":"1153_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/758314","volume":"2015","author":"A Malekzadeh","year":"2015","unstructured":"Malekzadeh, A. et al. Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines? Dis. Markers 2015, 758314 (2015).","journal-title":"Dis. Markers"},{"key":"1153_CR62","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2015.11.005","volume":"15","author":"R Patejdl","year":"2016","unstructured":"Patejdl, R., Penner, I. K., Noack, T. K. & Zettl, U. K. Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmun. Rev. 15, 210\u2013220 (2016).","journal-title":"Autoimmun. Rev."},{"key":"1153_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000087104","volume":"12","author":"IJ Elenkov","year":"2005","unstructured":"Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G. & Chrousos, G. P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12, 255\u2013269 (2005).","journal-title":"Neuroimmunomodulation"},{"key":"1153_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban, F. et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 101, 93\u2013135 (2022).","journal-title":"Brain Behav. Immun."},{"key":"1153_CR65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/JIR.S167199","volume":"11","author":"MA Chalah","year":"2018","unstructured":"Chalah, M. A. & Ayache, S. S. Is there a link between inflammation and fatigue in multiple sclerosis? J. Inflamm. Res. 11, 253\u2013264 (2018).","journal-title":"J. Inflamm. Res."},{"key":"1153_CR66","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1212\/WNL.57.4.676","volume":"57","author":"G Giovannoni","year":"2001","unstructured":"Giovannoni, G., Thompson, A. J., Miller, D. H. & Thompson, E. J. Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology 57, 676\u2013681 (2001).","journal-title":"Neurology"},{"key":"1153_CR67","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1191\/1352458504ms991oa","volume":"10","author":"P Flachenecker","year":"2004","unstructured":"Flachenecker, P. et al. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult. Scler. 10, 165\u2013169 (2004).","journal-title":"Mult. Scler."},{"key":"1153_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058643","volume":"8","author":"A Svenningsson","year":"2013","unstructured":"Svenningsson, A. et al. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS ONE 8, e58643 (2013).","journal-title":"PLoS ONE"},{"key":"1153_CR69","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jamaneurol.2021.0405","volume":"78","author":"L Kappos","year":"2021","unstructured":"Kappos, L. et al. Ponesimod compared with teriflunomide in patients with relapsing multiple sclerosis in the active-comparator phase 3 OPTIMUM study: a randomized clinical trial. JAMA Neurol. 78, 558\u2013567 (2021).","journal-title":"JAMA Neurol."},{"key":"1153_CR70","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1212\/WNL.48.6.1566","volume":"48","author":"U Roelcke","year":"1997","unstructured":"Roelcke, U. et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48, 1566\u20131571 (1997).","journal-title":"Neurology"},{"key":"1153_CR71","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ana.26290","volume":"91","author":"V Fleischer","year":"2022","unstructured":"Fleischer, V. et al. Subcortical volumes as early predictors of fatigue in multiple sclerosis. Ann. Neurol. 91, 192\u2013202 (2022).","journal-title":"Ann. Neurol."},{"key":"1153_CR72","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/1352458518758911","volume":"25","author":"S Jaeger","year":"2019","unstructured":"Jaeger, S. et al. Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex. Mult. Scler. 25, 554\u2013564 (2019).","journal-title":"Mult. Scler."},{"key":"1153_CR73","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200205","volume":"11","author":"P Preziosa","year":"2024","unstructured":"Preziosa, P. et al. Chronic active lesions and larger choroid plexus explain cognition and fatigue in multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 11, e200205 (2024).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1153_CR74","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jnnp-2024-334913","volume":"96","author":"M Rubin","year":"2025","unstructured":"Rubin, M. et al. Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 96, 443\u2013452 (2025).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1153_CR75","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/1352458519898112","volume":"26","author":"M Palotai","year":"2020","unstructured":"Palotai, M., Cavallari, M., Healy, B. C. & Guttmann, C. R. A novel classification of fatigue in multiple sclerosis based on longitudinal assessments. Mult. Scler. 26, 725\u2013734 (2020).","journal-title":"Mult. Scler."},{"key":"1153_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103955","volume":"64","author":"L Broch","year":"2022","unstructured":"Broch, L. et al. Fatigue in multiple sclerosis is associated with socioeconomic factors. Mult. Scler. Relat. Disord. 64, 103955 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1153_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652177","volume":"12","author":"GEA Pust","year":"2021","unstructured":"Pust, G. E. A. et al. Association of fatigue severity with maladaptive coping in multiple sclerosis: a data-driven psychodynamic perspective. Front. Neurol. 12, 652177 (2021).","journal-title":"Front. Neurol."},{"key":"1153_CR78","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7224\/1537-2073.2015-070","volume":"18","author":"KM Fiest","year":"2016","unstructured":"Fiest, K. M. et al. Fatigue and comorbidities in multiple sclerosis. Int. J. MS Care 18, 96\u2013104 (2016).","journal-title":"Int. J. MS Care"},{"key":"1153_CR79","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/NRE-210179","volume":"50","author":"E Wang","year":"2022","unstructured":"Wang, E., Chang, J. H. C. & Plow, M. Predictors of fatigue self-management behaviors in adults with multiple sclerosis. NeuroRehabilitation 50, 75\u201387 (2022).","journal-title":"NeuroRehabilitation"},{"key":"1153_CR80","doi-asserted-by":"publisher","first-page":"900792","DOI":"10.3389\/fneur.2022.900792","volume":"13","author":"M Grothe","year":"2022","unstructured":"Grothe, M., Gross, S., S\u00fc\u00dfe, M., Strauss, S. & Penner, I. K. The seasonal fluctuation of fatigue in multiple sclerosis. Front. Neurol. 13, 900792 (2022).","journal-title":"Front. Neurol."},{"key":"1153_CR81","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/mds.27461","volume":"33","author":"M Siciliano","year":"2018","unstructured":"Siciliano, M. et al. Fatigue in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 33, 1712\u20131723 (2018).","journal-title":"Mov. Disord."},{"key":"1153_CR82","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/ene.15411","volume":"29","author":"M Siciliano","year":"2022","unstructured":"Siciliano, M. et al. Validation of new diagnostic criteria for fatigue in patients with Parkinson disease. Eur. J. Neurol. 29, 2631\u20132638 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1153_CR83","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/mds.26511","volume":"31","author":"BM Kluger","year":"2016","unstructured":"Kluger, B. M. et al. Parkinson\u2019s disease-related fatigue: a case definition and recommendations for clinical research. Mov. Disord. 31, 625\u2013631 (2016).","journal-title":"Mov. Disord."},{"key":"1153_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.parkreldis.2021.03.018","volume":"86","author":"IA Di Vico","year":"2021","unstructured":"Di Vico, I. A. et al. Fatigue in hypokinetic, hyperkinetic, and functional movement disorders. Parkinsonism Relat. Disord. 86, 114\u2013123 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1153_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1133705","volume":"15","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Characteristics of fatigue in Parkinson\u2019s disease: a longitudinal cohort study. Front. Aging Neurosci. 15, 1133705 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1153_CR86","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3233\/JPD-213116","volume":"12","author":"M Bereau","year":"2022","unstructured":"Bereau, M. et al. Fatigue in de novo Parkinson\u2019s disease: expanding the neuropsychiatric triad? J. Parkinsons Dis. 12, 1329\u20131337 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1153_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578222","volume":"385","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Plasma TNF-\u03b1 and phosphorylated \u03b1-syn are associated with fatigue in patients with Parkinson\u2019s disease. J. Neuroimmunol. 385, 578222 (2023).","journal-title":"J. Neuroimmunol."},{"key":"1153_CR88","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fneur.2019.00195","volume":"10","author":"T Prell","year":"2019","unstructured":"Prell, T., Witte, O. W. & Grosskreutz, J. Biomarkers for dementia, fatigue, and depression in Parkinson\u2019s disease. Front. Neurol. 10, 195 (2019).","journal-title":"Front. Neurol."},{"key":"1153_CR89","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/brain\/awad338","volume":"147","author":"C Laurencin","year":"2024","unstructured":"Laurencin, C. et al. Noradrenergic alterations in Parkinson\u2019s disease: a combined 11C-yohimbine PET\/neuromelanin MRI study. Brain 147, 1377\u20131388 (2024).","journal-title":"Brain"},{"key":"1153_CR90","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JPD-225116","volume":"13","author":"AK Folkerts","year":"2023","unstructured":"Folkerts, A. K. et al. Physical exercise as a potential treatment for fatigue in Parkinson\u2019s disease? A systematic review and meta-analysis of pharmacological and non-pharmacological interventions. J. Parkinsons Dis. 13, 659\u2013679 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"1153_CR91","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi, K. et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov. Disord. 34, 180\u2013198 (2019).","journal-title":"Mov. Disord."},{"key":"1153_CR92","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s41999-017-0020-4","volume":"9","author":"SH Panagiotakis","year":"2018","unstructured":"Panagiotakis, S. H. et al. Self-reported fatigue as a risk index for dementia diagnosis. Eur. Geriatr. Med. 9, 211\u2013217 (2018).","journal-title":"Eur. Geriatr. Med."},{"key":"1153_CR93","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1016\/S2589-7500(21)00275-2","volume":"4","author":"T Nedelec","year":"2022","unstructured":"Nedelec, T. et al. Identifying health conditions associated with Alzheimer\u2019s disease up to 15 years before diagnosis: an agnostic study of French and British health records. Lancet Digit. Health 4, e169\u2013e178 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1153_CR94","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s40520-023-02482-z","volume":"35","author":"D Angioni","year":"2023","unstructured":"Angioni, D., Raffin, J., Ousset, P. J., Delrieu, J. & de Souto Barreto, P. Fatigue in Alzheimer\u2019s disease: biological basis and clinical management-a narrative review. Aging Clin. Exp. Res. 35, 1981\u20131989 (2023).","journal-title":"Aging Clin. Exp. Res."},{"key":"1153_CR95","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/arclin\/acy032","volume":"34","author":"C Vila-Castelar","year":"2019","unstructured":"Vila-Castelar, C. et al. Attention measures of accuracy, variability, and fatigue detect early response to donepezil in Alzheimer\u2019s disease: a randomized, double-blind, placebo-controlled pilot trial. Arch. Clin. Neuropsychol. 34, 277\u2013289 (2019).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"1153_CR96","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/jnnp-2020-323497","volume":"91","author":"L Lu","year":"2020","unstructured":"Lu, L. et al. Anti-A\u03b2 agents for mild to moderate Alzheimer\u2019s disease: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 91, 1316\u20131324 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1153_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.852486","volume":"13","author":"I Kirchberger","year":"2022","unstructured":"Kirchberger, I. et al. Factors associated with early and late post-stroke fatigue in patients with mild impairment. results from the Stroke Cohort Study Augsburg. Front. Neurol. 13, 852486 (2022).","journal-title":"Front. Neurol."},{"key":"1153_CR98","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/23969873211047681","volume":"6","author":"I Alghamdi","year":"2021","unstructured":"Alghamdi, I., Ariti, C., Williams, A., Wood, E. & Hewitt, J. Prevalence of fatigue after stroke: a systematic review and meta-analysis. Eur. Stroke J. 6, 319\u2013332 (2021).","journal-title":"Eur. Stroke J."},{"key":"1153_CR99","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1177\/17474930221138701","volume":"18","author":"J Zhan","year":"2023","unstructured":"Zhan, J. et al. Global prevalence estimates of poststroke fatigue: a systematic review and meta-analysis. Int. J. Stroke 18, 1040\u20131050 (2023).","journal-title":"Int. J. Stroke"},{"key":"1153_CR100","doi-asserted-by":"publisher","first-page":"1298915","DOI":"10.3389\/fneur.2023.1298915","volume":"14","author":"W Chen","year":"2023","unstructured":"Chen, W., Jiang, T., Huang, H. & Zeng, J. Post-stroke fatigue: a review of development, prevalence, predisposing factors, measurements, and treatments. Front. Neurol. 14, 1298915 (2023).","journal-title":"Front. Neurol."},{"key":"1153_CR101","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11910-023-01282-2","volume":"23","author":"DL Alsbrook","year":"2023","unstructured":"Alsbrook, D. L. et al. Neuroinflammation in acute ischemic and hemorrhagic stroke. Curr. Neurol. Neurosci. Rep. 23, 407\u2013431 (2023).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"Suppl. 3","key":"1153_CR102","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/j.nmd.2012.10.014","volume":"22","author":"IS Merkies","year":"2012","unstructured":"Merkies, I. S. & Faber, C. G. Fatigue in immune-mediated neuropathies. Neuromuscul. Disord. 22 Suppl. 3, S203\u2013S207 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"1153_CR103","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","volume":"53","author":"IS Merkies","year":"1999","unstructured":"Merkies, I. S., Schmitz, P. I., Samijn, J. P., van der Meche, F. G. & van Doorn, P. A. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53, 1648\u20131654 (1999).","journal-title":"Neurology"},{"key":"1153_CR104","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mus.27038","volume":"62","author":"KL Gable","year":"2020","unstructured":"Gable, K. L., Attarian, H. & Allen, J. A. Fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 62, 673\u2013680 (2020).","journal-title":"Muscle Nerve"},{"key":"1153_CR105","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/mus.26913","volume":"62","author":"A Lawley","year":"2020","unstructured":"Lawley, A., Abbas, A., Seri, S. & Rajabally, Y. A. Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 62, 226\u2013232 (2020).","journal-title":"Muscle Nerve"},{"key":"1153_CR106","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cnp.2022.02.003","volume":"7","author":"A Tsuneyama","year":"2022","unstructured":"Tsuneyama, A. et al. Fatigue and activity-dependent conduction block in neuromuscular disorders. Clin. Neurophysiol. Pract. 7, 71\u201377 (2022).","journal-title":"Clin. Neurophysiol. Pract."},{"key":"1153_CR107","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/mus.28274","volume":"71","author":"JM Gabet","year":"2025","unstructured":"Gabet, J. M. et al. Neuralgic amyotrophy: an update in evaluation, diagnosis, and treatment approaches. Muscle Nerve 71, 846\u2013856 (2025).","journal-title":"Muscle Nerve"},{"key":"1153_CR108","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1007\/s00415-024-12473-3","volume":"271","author":"M Wiemann","year":"2024","unstructured":"Wiemann, M. et al. The role of fatigue in patients with complex regional pain syndrome. J. Neurol. 271, 5246\u20135255 (2024).","journal-title":"J. Neurol."},{"key":"1153_CR109","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/brain\/123.8.1602","volume":"123","author":"R Kaji","year":"2000","unstructured":"Kaji, R. et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain 123, 1602\u20131611 (2000).","journal-title":"Brain"},{"key":"1153_CR110","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clinph.2006.10.018","volume":"118","author":"ML Schillings","year":"2007","unstructured":"Schillings, M. L. et al. Experienced and physiological fatigue in neuromuscular disorders. Clin. Neurophysiol. 118, 292\u2013300 (2007).","journal-title":"Clin. Neurophysiol."},{"key":"1153_CR111","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jns5.12037","volume":"18","author":"A Kerasnoudis","year":"2013","unstructured":"Kerasnoudis, A., Pitarokoili, K., Behrendt, V., Gold, R. & Yoon, M. S. Correlation of nerve ultrasound, electrophysiological, and clinical findings in post Guillain\u2013Barre syndrome. J. Peripher. Nerv. Syst. 18, 232\u2013240 (2013).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"1153_CR112","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/acn3.51133","volume":"7","author":"NE Fritz","year":"2020","unstructured":"Fritz, N. E. et al. Fatigue in patients with hereditary neuropathy with liability to pressure palsies. Ann. Clin. Transl. Neurol. 7, 1400\u20131409 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1153_CR113","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers, D. R. & Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 18, 211\u2013220 (2019).","journal-title":"Lancet Neurol."},{"key":"1153_CR114","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/21678421.2020.1760889","volume":"21","author":"KT Brizzi","year":"2020","unstructured":"Brizzi, K. T. et al. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 355\u2013363 (2020).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"1153_CR115","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1007\/s00415-023-12141-y","volume":"271","author":"K Stenson","year":"2024","unstructured":"Stenson, K. et al. Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey. J. Neurol. 271, 2390\u20132404 (2024).","journal-title":"J. Neurol."},{"key":"1153_CR116","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/21678421.2023.2249515","volume":"24","author":"E Conroy","year":"2023","unstructured":"Conroy, E. et al. IMPACT-ALS: summary of results from a European survey of people living with ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 24, 641\u2013650 (2023).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"1153_CR117","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00415-021-10651-1","volume":"269","author":"E Beswick","year":"2022","unstructured":"Beswick, E. et al. A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J. Neurol. 269, 411\u2013426 (2022).","journal-title":"J. Neurol."},{"key":"1153_CR118","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10072-023-07119-7","volume":"45","author":"AA Hamad","year":"2024","unstructured":"Hamad, A. A., Amer, B. E., Abbas, N. B., Alnajjar, A. Z. & Meshref, M. Prevalence and correlates of fatigue in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol. Sci. 45, 485\u2013493 (2024).","journal-title":"Neurol. Sci."},{"key":"1153_CR119","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mus.25712","volume":"57","author":"K Nicholson","year":"2018","unstructured":"Nicholson, K. et al. Improving symptom management for people with amyotrophic lateral sclerosis. Muscle Nerve 57, 20\u201324 (2018).","journal-title":"Muscle Nerve"},{"key":"1153_CR120","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(23)00155-2","volume":"22","author":"RM van Eenennaam","year":"2023","unstructured":"van Eenennaam, R. M. et al. Frequency of euthanasia, factors associated with end-of-life practices, and quality of end-of-life care in patients with amyotrophic lateral sclerosis in the Netherlands: a population-based cohort study. Lancet Neurol. 22, 591\u2013601 (2023).","journal-title":"Lancet Neurol."},{"key":"1153_CR121","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40263-021-00820-1","volume":"35","author":"CJ Mahoney","year":"2021","unstructured":"Mahoney, C. J. et al. Pathophysiology and treatment of non-motor dysfunction in amyotrophic lateral sclerosis. CNS Drugs 35, 483\u2013505 (2021).","journal-title":"CNS Drugs"},{"key":"1153_CR122","first-page":"CD011005","volume":"1","author":"C Gibbons","year":"2018","unstructured":"Gibbons, C., Pagnini, F., Friede, T. & Young, C. A. Treatment of fatigue in amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst. Rev. 1, CD011005 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1153_CR123","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/mus.21493","volume":"41","author":"CJ Symonette","year":"2010","unstructured":"Symonette, C. J., Watson, B. V., Koopman, W. J., Nicolle, M. W. & Doherty, T. J. Muscle strength and fatigue in patients with generalized myasthenia gravis. Muscle Nerve 41, 362\u2013369 (2010).","journal-title":"Muscle Nerve"},{"key":"1153_CR124","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/1097-4598(200009)23:9<1402::AID-MUS11>3.0.CO;2-B","volume":"23","author":"RH Paul","year":"2000","unstructured":"Paul, R. H., Cohen, R. A., Goldstein, J. M. & Gilchrist, J. M. Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23, 1402\u20131406 (2000).","journal-title":"Muscle Nerve"},{"key":"1153_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-132","volume":"13","author":"A Elsais","year":"2013","unstructured":"Elsais, A., Wyller, V. B., Loge, J. H. & Kerty, E. Fatigue in myasthenia gravis: is it more than muscular weakness? BMC Neurol. 13, 132 (2013).","journal-title":"BMC Neurol."},{"key":"1153_CR126","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.nmd.2020.06.010","volume":"30","author":"AM Ruiter","year":"2020","unstructured":"Ruiter, A. M., Verschuuren, J. & Tannemaat, M. R. Fatigue in patients with myasthenia gravis. a systematic review of the literature. Neuromuscul. Disord. 30, 631\u2013639 (2020).","journal-title":"Neuromuscul. Disord."},{"key":"1153_CR127","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1007\/s00415-024-12490-2","volume":"271","author":"M Funke","year":"2024","unstructured":"Funke, M. et al. Fatigue and associated factors in myasthenia gravis: a nationwide registry study. J. Neurol. 271, 5665\u20135670 (2024).","journal-title":"J. Neurol."},{"key":"1153_CR128","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/mus.26069","volume":"58","author":"C Tran","year":"2018","unstructured":"Tran, C., Bril, V., Katzberg, H. D. & Barnett, C. Fatigue is a relevant outcome in patients with myasthenia gravis. Muscle Nerve 58, 197\u2013203 (2018).","journal-title":"Muscle Nerve"},{"key":"1153_CR129","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s11136-019-02148-2","volume":"28","author":"H Andersen","year":"2019","unstructured":"Andersen, H. et al. Eculizumab improves fatigue in refractory generalized myasthenia gravis. Qual. Life Res. 28, 2247\u20132254 (2019).","journal-title":"Qual. Life Res."},{"key":"1153_CR130","doi-asserted-by":"publisher","DOI":"10.1177\/17562864241243186","volume":"17","author":"JF Howard Jr.","year":"2024","unstructured":"Howard, J. F. Jr. et al. Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Ther. Adv. Neurol. Disord. 17, 17562864241243186 (2024).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1153_CR131","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1007\/s00415-022-11517-w","volume":"270","author":"F Sacca","year":"2023","unstructured":"Sacca, F. et al. Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT). J. Neurol. 270, 2096\u20132105 (2023).","journal-title":"J. Neurol."},{"key":"1153_CR132","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00415-019-09374-1","volume":"266","author":"TM Alekseeva","year":"2019","unstructured":"Alekseeva, T. M. et al. Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis. J. Neurol. 266, 2027\u20132034 (2019).","journal-title":"J. Neurol."},{"key":"1153_CR133","first-page":"1041","volume":"27","author":"F Roila","year":"2019","unstructured":"Roila, F. et al. Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO). Support Care Cancer 27, 1041\u20131047 (2019).","journal-title":"Support Care Cancer"},{"key":"1153_CR134","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","volume":"21","author":"MSY Thong","year":"2020","unstructured":"Thong, M. S. Y., van Noorden, C. J. F., Steindorf, K. & Arndt, V. Cancer-related fatigue: causes and current treatment options. Curr. Treat. Options Oncol. 21, 17 (2020).","journal-title":"Curr. Treat. Options Oncol."},{"key":"1153_CR135","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10067-015-3035-6","volume":"35","author":"CL Overman","year":"2016","unstructured":"Overman, C. L., Kool, M. B., Da Silva, J. A. & Geenen, R. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin. Rheumatol. 35, 409\u2013415 (2016).","journal-title":"Clin. Rheumatol."},{"key":"1153_CR136","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/art.21450","volume":"53","author":"S Hewlett","year":"2005","unstructured":"Hewlett, S. et al. Patients\u2019 perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum. 53, 697\u2013702 (2005).","journal-title":"Arthritis Rheum."},{"key":"1153_CR137","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/rheumatology\/keq009","volume":"49","author":"WF Ng","year":"2010","unstructured":"Ng, W. F. & Bowman, S. J. Primary Sjogren\u2019s syndrome: too dry and too tired. Rheumatology 49, 844\u2013853 (2010).","journal-title":"Rheumatology"},{"key":"1153_CR138","first-page":"1407","volume":"23","author":"F Wolfe","year":"1996","unstructured":"Wolfe, F., Hawley, D. J. & Wilson, K. The prevalence and meaning of fatigue in rheumatic disease. J. Rheumatol. 23, 1407\u20131417 (1996).","journal-title":"J. Rheumatol."},{"key":"1153_CR139","doi-asserted-by":"publisher","first-page":"v29","DOI":"10.1093\/rheumatology\/kez346","volume":"58","author":"KL Druce","year":"2019","unstructured":"Druce, K. L. & Basu, N. Predictors of fatigue in rheumatoid arthritis. Rheumatology 58, v29\u2013v34 (2019).","journal-title":"Rheumatology"},{"key":"1153_CR140","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000885","volume":"5","author":"KL Hackett","year":"2019","unstructured":"Hackett, K. L. et al. Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjogren\u2019s syndrome. RMD Open 5, e000885 (2019).","journal-title":"RMD Open"},{"key":"1153_CR141","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/PSY.0000000000000498","volume":"79","author":"N Basu","year":"2017","unstructured":"Basu, N., Jones, G. T., Macfarlane, G. J. & Druce, K. L. Identification and validation of clinically relevant clusters of severe fatigue in rheumatoid arthritis. Psychosom. Med. 79, 1051\u20131058 (2017).","journal-title":"Psychosom. Med."},{"key":"1153_CR142","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s41927-024-00423-5","volume":"8","author":"L Leon","year":"2024","unstructured":"Leon, L. et al. The potential role of fatigue in difficult-to-treat rheumatoid arthritis. BMC Rheumatol. 8, 49 (2024).","journal-title":"BMC Rheumatol."},{"key":"1153_CR143","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00296-019-04354-0","volume":"39","author":"K Davies","year":"2019","unstructured":"Davies, K. et al. Fatigue in primary Sjogren\u2019s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study. Rheumatol. Int. 39, 1867\u20131873 (2019).","journal-title":"Rheumatol. Int."},{"key":"1153_CR144","doi-asserted-by":"publisher","first-page":"703079","DOI":"10.3389\/fimmu.2021.703079","volume":"12","author":"E Maeland","year":"2021","unstructured":"Maeland, E., Miyamoto, S. T., Hammenfors, D., Valim, V. & Jonsson, M. V. Understanding fatigue in Sjogren\u2019s syndrome: outcome measures, biomarkers and possible interventions. Front. Immunol. 12, 703079 (2021).","journal-title":"Front. Immunol."},{"key":"1153_CR145","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1016\/j.celrep.2020.02.109","volume":"30","author":"P Suss","year":"2020","unstructured":"Suss, P. et al. Chronic peripheral inflammation causes a region-specific myeloid response in the central nervous system. Cell Rep. 30, 4082\u20134095.e4086 (2020).","journal-title":"Cell Rep."},{"key":"1153_CR146","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/rheumatology\/keu387","volume":"54","author":"N van Leeuwen","year":"2015","unstructured":"van Leeuwen, N. et al. Psychological profiles in patients with Sjogren\u2019s syndrome related to fatigue: a cluster analysis. Rheumatology 54, 776\u2013783 (2015).","journal-title":"Rheumatology"},{"key":"1153_CR147","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1080\/13548506.2020.1736312","volume":"25","author":"B Shen","year":"2020","unstructured":"Shen, B. et al. Effects of cognitive behavioral therapy for patients with rheumatoid arthritis: a systematic review and meta-analysis. Psychol. Health Med. 25, 1179\u20131191 (2020).","journal-title":"Psychol. Health Med."},{"key":"1153_CR148","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/rheumatology\/kew008","volume":"55","author":"K Braekke Norheim","year":"2016","unstructured":"Braekke Norheim, K. et al. Epigenome-wide DNA methylation patterns associated with fatigue in primary Sjogren\u2019s syndrome. Rheumatology 55, 1074\u20131082 (2016).","journal-title":"Rheumatology"},{"key":"1153_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1502-8","volume":"16","author":"K Bardsen","year":"2019","unstructured":"Bardsen, K. et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjogren\u2019s syndrome. J. Neuroinflammation 16, 102 (2019).","journal-title":"J. Neuroinflammation"},{"key":"1153_CR150","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119850390","volume":"7","author":"E Larssen","year":"2019","unstructured":"Larssen, E. et al. Fatigue in primary Sjogren\u2019s syndrome: a proteomic pilot study of cerebrospinal fluid. SAGE Open Med. 7, 2050312119850390 (2019).","journal-title":"SAGE Open Med."},{"key":"1153_CR151","unstructured":"National Guideline Centre. Monitoring and Reviewing People with ME\/CFS: Myalgic Encephalomyelitis (or Encephalopathy)\/Chronic Fatigue Syndrome: Diagnosis And Management. Evidence Review J (National Institute for Health and Care Excellence, 2021)."},{"key":"1153_CR152","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1080\/09638288.2023.2242783","volume":"46","author":"R Hersche","year":"2024","unstructured":"Hersche, R., Weise, A., Hummel, B. & Barbero, M. Occupational therapy-based self-management education in persons with post-COVID-19 condition related fatigue: a feasibility study with a pre-post design. Disabil. Rehabil. 46, 3060\u20133066 (2024).","journal-title":"Disabil. Rehabil."},{"key":"1153_CR153","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-1002-3","volume":"19","author":"U Dalgas","year":"2019","unstructured":"Dalgas, U., Langeskov-Christensen, M., Stenager, E., Riemenschneider, M. & Hvid, L. G. Exercise as medicine in multiple sclerosis-time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives. Curr. Neurol. Neurosci. Rep. 19, 88 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1153_CR154","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.3390\/ijms21165895","volume":"21","author":"B Mahalakshmi","year":"2020","unstructured":"Mahalakshmi, B., Maurya, N., Lee, S. D. & Bharath Kumar, V. Possible neuroprotective mechanisms of physical exercise in neurodegeneration. Int J. Mol. Sci. 21, 5895 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"1153_CR155","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1177\/1352458521996002","volume":"27","author":"AM Harrison","year":"2021","unstructured":"Harrison, A. M. et al. Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis. Mult. Scler. 27, 1657\u20131678 (2021).","journal-title":"Mult. Scler."},{"key":"1153_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44432-3","volume":"15","author":"B Appelman","year":"2024","unstructured":"Appelman, B. et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 15, 17 (2024).","journal-title":"Nat. Commun."},{"key":"1153_CR157","first-page":"194","volume":"67","author":"H Greenlee","year":"2017","unstructured":"Greenlee, H. et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J. Clin. 67, 194\u2013232 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"1153_CR158","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pscychresns.2010.08.006","volume":"191","author":"BK H\u00f6lzel","year":"2011","unstructured":"H\u00f6lzel, B. K. et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res. 191, 36\u201343 (2011).","journal-title":"Psychiatry Res."},{"key":"1153_CR159","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.copsyc.2018.11.009","volume":"28","author":"QA Conklin","year":"2019","unstructured":"Conklin, Q. A., Crosswell, A. D., Saron, C. D. & Epel, E. S. Meditation, stress processes, and telomere biology. Curr. Opin. Psychol. 28, 92\u2013101 (2019).","journal-title":"Curr. Opin. Psychol."},{"key":"1153_CR160","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/08870446.2019.1707827","volume":"35","author":"NS Schutte","year":"2020","unstructured":"Schutte, N. S., Malouff, J. M. & Keng, S. L. Meditation and telomere length: a meta-analysis. Psychol. Health 35, 901\u2013915 (2020).","journal-title":"Psychol. Health"},{"key":"1153_CR161","unstructured":"Kabat-Zinn, J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness (Delacorte, 1990)."},{"key":"1153_CR162","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1007\/s00415-023-11616-2","volume":"270","author":"SJ Baetge","year":"2023","unstructured":"Baetge, S. J. et al. Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms. J. Neurol. 270, 3058\u20133071 (2023).","journal-title":"J. Neurol."},{"key":"1153_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269519","volume":"17","author":"E Chayadi","year":"2022","unstructured":"Chayadi, E., Baes, N. & Kiropoulos, L. The effects of mindfulness-based interventions on symptoms of depression, anxiety, and cancer-related fatigue in oncology patients: a systematic review and meta-analysis. PLoS ONE 17, e0269519 (2022).","journal-title":"PLoS ONE"},{"key":"1153_CR164","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/WNL.0b013e3181f4d80d","volume":"75","author":"P Grossman","year":"2010","unstructured":"Grossman, P. et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 75, 1141\u20131149 (2010).","journal-title":"Neurology"},{"key":"1153_CR165","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-981-32-9705-0_17","volume":"1191","author":"J Apolinario-Hagen","year":"2020","unstructured":"Apolinario-Hagen, J., Druge, M. & Fritsche, L. Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: integrating traditional with digital treatment approaches. Adv. Exp. Med. Biol. 1191, 291\u2013329 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1153_CR166","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/PSY.0b013e3181643065","volume":"70","author":"K van Kessel","year":"2008","unstructured":"van Kessel, K. et al. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom. Med. 70, 205\u2013213 (2008).","journal-title":"Psychosom. Med."},{"key":"1153_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2019.103464","volume":"137","author":"R Moss-Morris","year":"2021","unstructured":"Moss-Morris, R. et al. Which behavioural and exercise interventions targeting fatigue show the most promise in multiple sclerosis? A systematic review with narrative synthesis and meta-analysis. Behav. Res. Ther. 137, 103464 (2021).","journal-title":"Behav. Res. Ther."},{"key":"1153_CR168","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41593-017-0054-4","volume":"21","author":"R Polania","year":"2018","unstructured":"Polania, R., Nitsche, M. A. & Ruff, C. C. Studying and modifying brain function with non-invasive brain stimulation. Nat. Neurosci. 21, 174\u2013187 (2018).","journal-title":"Nat. Neurosci."},{"key":"1153_CR169","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211069198","volume":"13","author":"RLD Kan","year":"2022","unstructured":"Kan, R. L. D. et al. Effects of non-invasive brain stimulation in multiple sclerosis: systematic review and meta-analysis. Ther. Adv. Chronic Dis. 13, 20406223211069198 (2022).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"1153_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104927","volume":"78","author":"E Uygur-Kucukseymen","year":"2023","unstructured":"Uygur-Kucukseymen, E. et al. Non-invasive brain stimulation on clinical symptoms in multiple sclerosis patients: a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 78, 104927 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1153_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1007702","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Non-invasive brain stimulation therapy on neurological symptoms in patients with multiple sclerosis: a network meta analysis. Front. Neurol. 13, 1007702 (2022).","journal-title":"Front. Neurol."},{"key":"1153_CR172","doi-asserted-by":"publisher","first-page":"fcad117","DOI":"10.1093\/braincomms\/fcad117","volume":"5","author":"S Oliver-Mas","year":"2023","unstructured":"Oliver-Mas, S. et al. Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study. Brain Commun. 5, fcad117 (2023).","journal-title":"Brain Commun."},{"key":"1153_CR173","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10072-016-2748-x","volume":"38","author":"B Forogh","year":"2017","unstructured":"Forogh, B. et al. Repeated sessions of transcranial direct current stimulation evaluation on fatigue and daytime sleepiness in Parkinson\u2019s disease. Neurol. Sci. 38, 249\u2013254 (2017).","journal-title":"Neurol. Sci."},{"key":"1153_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836824","volume":"13","author":"CM Flessa","year":"2022","unstructured":"Flessa, C. M. et al. Genetic variants of the BAFF gene and risk of fatigue among patients with primary Sjogren\u2019s syndrome. Front. Immunol. 13, 836824 (2022).","journal-title":"Front. Immunol."},{"key":"1153_CR175","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower, J. E. Cancer-related fatigue\u2013mechanisms, risk factors, and treatments. Nat. Rev. Clin. Oncol. 11, 597\u2013609 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1153_CR176","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2017.01.007","volume":"62","author":"T Wang","year":"2017","unstructured":"Wang, T., Yin, J., Miller, A. H. & Xiao, C. A systematic review of the association between fatigue and genetic polymorphisms. Brain Behav. Immun. 62, 230\u2013244 (2017).","journal-title":"Brain Behav. Immun."},{"key":"1153_CR177","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41584-021-00692-1","volume":"17","author":"K Davies","year":"2021","unstructured":"Davies, K., Dures, E. & Ng, W. F. Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research. Nat. Rev. Rheumatol. 17, 651\u2013664 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1153_CR178","doi-asserted-by":"publisher","first-page":"102884","DOI":"10.1016\/j.humov.2021.102884","volume":"80","author":"KL Kowalski","year":"2021","unstructured":"Kowalski, K. L., Boolani, A. & Christie, A. D. Sex differences in the impact of state and trait fatigue on gait variability. Hum. Mov. Sci. 80, 102884 (2021).","journal-title":"Hum. Mov. Sci."},{"key":"1153_CR179","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/ijerph19073909","volume":"19","author":"JF Tornero-Aguilera","year":"2022","unstructured":"Tornero-Aguilera, J. F., Jimenez-Morcillo, J., Rubio-Zarapuz, A. & Clemente-Suarez, V. J. Central and peripheral fatigue in physical exercise explained: a narrative review. Int. J. Environ. Res. Public Health 19, 3909 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1153_CR180","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/jnnp.2005.065805","volume":"77","author":"C Heesen","year":"2006","unstructured":"Heesen, C. et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J. Neurol. Neurosurg. Psychiatry 77, 34\u201339 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1153_CR181","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/cells8070738","volume":"8","author":"S Yang","year":"2019","unstructured":"Yang, S. et al. A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis. Cells 8, 738 (2019).","journal-title":"Cells"},{"key":"1153_CR182","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2019.03.007","volume":"400","author":"J Arm","year":"2019","unstructured":"Arm, J., Ribbons, K., Lechner-Scott, J. & Ramadan, S. Evaluation of MS related central fatigue using MR neuroimaging methods: scoping review. J. Neurol. Sci. 400, 52\u201371 (2019).","journal-title":"J. Neurol. Sci."},{"key":"1153_CR183","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/neurolint14020042","volume":"14","author":"C Barbi","year":"2022","unstructured":"Barbi, C. et al. Brain structural and functional alterations in multiple sclerosis-related fatigue: a systematic review. Neurol. Int. 14, 506\u2013535 (2022).","journal-title":"Neurol. Int."},{"key":"1153_CR184","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60368-0","volume":"14","author":"C Delgado-Alonso","year":"2024","unstructured":"Delgado-Alonso, C. et al. Cognitive profile in multiple sclerosis and post-COVID condition: a comparative study using a unified taxonomy. Sci. Rep. 14, 9806 (2024).","journal-title":"Sci. Rep."},{"key":"1153_CR185","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/brain\/awac384","volume":"146","author":"M Diez-Cirarda","year":"2023","unstructured":"Diez-Cirarda, M. et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain 146, 2142\u20132152 (2023).","journal-title":"Brain"},{"key":"1153_CR186","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0022-510X(99)00205-1","volume":"170","author":"JC Keesey","year":"1999","unstructured":"Keesey, J. C. Does myasthenia gravis affect the brain? J. Neurol. Sci. 170, 77\u201389 (1999).","journal-title":"J. Neurol. Sci."},{"key":"1153_CR187","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/archneurol.2011.200","volume":"68","author":"A Vaknin-Dembinsky","year":"2011","unstructured":"Vaknin-Dembinsky, A. et al. Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle? Arch. Neurol. 68, 1557\u20131561 (2011).","journal-title":"Arch. Neurol."},{"key":"1153_CR188","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fneur.2014.00264","volume":"5","author":"K Hanken","year":"2014","unstructured":"Hanken, K., Eling, P. & Hildebrandt, H. The representation of inflammatory signals in the brain \u2014 a model for subjective fatigue in multiple sclerosis. Front. Neurol. 5, 264 (2014).","journal-title":"Front. Neurol."},{"key":"1153_CR189","doi-asserted-by":"publisher","first-page":"100201","DOI":"10.1016\/j.bbih.2021.100201","volume":"12","author":"LSY Tan","year":"2021","unstructured":"Tan, L. S. Y., Francis, H. M. & Lim, C. K. Exploring the roles of tryptophan metabolism in MS beyond neuroinflammation and neurodegeneration: a paradigm shift to neuropsychiatric symptoms. Brain Behav. Immun. Health 12, 100201 (2021).","journal-title":"Brain Behav. Immun. Health"},{"key":"1153_CR190","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/archneur.62.2.277","volume":"62","author":"M Gottschalk","year":"2005","unstructured":"Gottschalk, M. et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 62, 277\u2013280 (2005).","journal-title":"Arch. Neurol."},{"key":"1153_CR191","doi-asserted-by":"publisher","first-page":"102533","DOI":"10.1016\/j.msard.2020.102533","volume":"46","author":"H Ormstad","year":"2020","unstructured":"Ormstad, H. et al. Chronic fatigue and depression due to multiple sclerosis: immune-inflammatory pathways, tryptophan catabolites and the gut\u2013brain axis as possible shared pathways. Mult. Scler. Relat. Disord. 46, 102533 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1153_CR192","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024358118","volume":"118","author":"BD Paul","year":"2021","unstructured":"Paul, B. D., Lemle, M. D., Komaroff, A. L. & Snyder, S. H. Redox imbalance links COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome. Proc. Natl Acad. Sci. USA 118, e2024358118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1153_CR193","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3389\/fimmu.2019.01827","volume":"10","author":"MR Zielinski","year":"2019","unstructured":"Zielinski, M. R., Systrom, D. M. & Rose, N. R. Fatigue, sleep, and autoimmune and related disorders. Front. Immunol. 10, 1827 (2019).","journal-title":"Front. Immunol."},{"key":"1153_CR194","doi-asserted-by":"publisher","first-page":"813965","DOI":"10.3389\/fneur.2022.813965","volume":"13","author":"SS Ayache","year":"2022","unstructured":"Ayache, S. S., Serratrice, N., Abi Lahoud, G. N. & Chalah, M. A. Fatigue in multiple sclerosis: a review of the exploratory and therapeutic potential of non-invasive brain stimulation. Front. Neurol. 13, 813965 (2022).","journal-title":"Front. Neurol."},{"key":"1153_CR195","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.biopsych.2015.05.015","volume":"79","author":"NG Dowell","year":"2016","unstructured":"Dowell, N. G. et al. Acute changes in striatal microstructure predict the development of interferon-\u03b1 induced fatigue. Biol. Psychiatry 79, 320\u2013328 (2016).","journal-title":"Biol. Psychiatry"},{"key":"1153_CR196","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1177\/1352458520972279","volume":"28","author":"H Heitmann","year":"2022","unstructured":"Heitmann, H. et al. Fatigue, depression, and pain in multiple sclerosis: how neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms. Mult. Scler. 28, 1020\u20131027 (2022).","journal-title":"Mult. Scler."},{"key":"1153_CR197","volume":"9","author":"JJ Bhattarai","year":"2023","unstructured":"Bhattarai, J. J. et al. Sleep disturbance and fatigue in multiple sclerosis: a systematic review and meta-analysis. Mult. Scler. J. Exp. Transl. Clin. 9, 20552173231194352 (2023).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"1153_CR198","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1111\/ene.14956","volume":"28","author":"TJ Weiland","year":"2021","unstructured":"Weiland, T. J. et al. Two healthy lifestyle scores are associated with lower subsequent fatigue risk using inverse probability weighting in an international longitudinal cohort of people with multiple sclerosis. Eur. J. Neurol. 28, 2952\u20132964 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1153_CR199","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-clinpsy-080621-045153","volume":"19","author":"JE Bower","year":"2023","unstructured":"Bower, J. E. & Kuhlman, K. R. Psychoneuroimmunology: an introduction to immune-to-brain communication and its implications for clinical psychology. Annu. Rev. Clin. Psychol. 19, 331\u2013359 (2023).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"1153_CR200","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","volume":"37","author":"JE Schwartz","year":"1993","unstructured":"Schwartz, J. E., Jandorf, L. & Krupp, L. B. The measurement of fatigue: a new instrument. J. Psychosom. Res. 37, 753\u2013762 (1993).","journal-title":"J. Psychosom. Res."},{"key":"1153_CR201","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets, E. M., Garssen, B., Bonke, B. & De Haes, J. C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39, 315\u2013325 (1995).","journal-title":"J. Psychosom. Res."},{"key":"1153_CR202","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0003-9993(96)90162-8","volume":"77","author":"CE Schwartz","year":"1996","unstructured":"Schwartz, C. E., Coulthard-Morris, L. & Zeng, Q. Psychosocial correlates of fatigue in multiple sclerosis. Arch. Phys. Med. Rehabil. 77, 165\u2013170 (1996).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"1153_CR203","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/archneur.1996.00550070080014","volume":"53","author":"JH Vercoulen","year":"1996","unstructured":"Vercoulen, J. H. et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch. Neurol. 53, 642\u2013649 (1996).","journal-title":"Arch. Neurol."},{"key":"1153_CR204","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1212\/WNL.47.1.129","volume":"47","author":"DF Cella","year":"1996","unstructured":"Cella, D. F. et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 47, 129\u2013139 (1996).","journal-title":"Neurology"},{"key":"1153_CR205","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/135245859900500103","volume":"5","author":"J Iriarte","year":"1999","unstructured":"Iriarte, J., Katsamakis, G. & de Castro, P. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult. Scler. 5, 10\u201316 (1999).","journal-title":"Mult. Scler."},{"key":"1153_CR206","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jval.2018.11.007","volume":"22","author":"S Hudgens","year":"2019","unstructured":"Hudgens, S. et al. Development and validation of the FSIQ-RMS: a new patient-reported questionnaire to assess symptoms and impacts of fatigue in relapsing multiple sclerosis. Value Health 22, 453\u2013466 (2019).","journal-title":"Value Health"},{"key":"1153_CR207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2004.07.007","volume":"11","author":"RG Brown","year":"2005","unstructured":"Brown, R. G., Dittner, A., Findley, L. & Wessely, S. C. The Parkinson fatigue scale. Parkinsonism Relat. Disord. 11, 49\u201355 (2005).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1153_CR208","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C. & Kaplan, E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J. Pain Symptom Manage. 13, 63\u201374 (1997).","journal-title":"J. Pain Symptom Manage."},{"key":"1153_CR209","volume-title":"Manual for the Profile of Mood State","author":"D McNair","year":"1971","unstructured":"McNair, D., Lorr, M., Droppleman, L. Manual for the Profile of Mood State (Educational and Industrial Testing Service, 1971)."},{"key":"1153_CR210","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0022-3999(02)00392-6","volume":"54","author":"HJ Michielsen","year":"2003","unstructured":"Michielsen, H. J., De Vries, J. & Van Heck, G. L. Psychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scale. J. Psychosom. Res. 54, 345\u2013352 (2003).","journal-title":"J. Psychosom. Res."},{"key":"1153_CR211","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1212\/01.wnl.0000242887.79115.19","volume":"67","author":"Z Simmons","year":"2006","unstructured":"Simmons, Z. et al. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 67, 1659\u20131664 (2006).","journal-title":"Neurology"},{"key":"1153_CR212","unstructured":"National Institute of Neurological Disorders and Stroke. User Manual for the Quality of Life in Neurological Disorders (Neuro[1]QoL) measures (Version 3.0) https:\/\/www.healthmeasures.net\/images\/neuro_qol\/User_and_scoring_guides\/Neuro-QOL_User_Manual_v3_26Apr2021_FINAL.pdf (2021)."},{"key":"1153_CR213","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01376517-199806000-00007","volume":"30","author":"ME Grohar-Murray","year":"1998","unstructured":"Grohar-Murray, M. E., Becker, A., Reilly, S. & Ricci, M. Self-care actions to manage fatigue among myasthenia gravis patients. J. Neurosci. Nurs. 30, 191\u2013199 (1998).","journal-title":"J. Neurosci. Nurs."},{"key":"1153_CR214","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/rheumatology\/keh170","volume":"43","author":"SJ Bowman","year":"2004","unstructured":"Bowman, S. J., Booth, D. A., Platts, R. G. & UK Sj\u00f6gren\u2019s Interest Group Measurement of fatigue and discomfort in primary Sjogren\u2019s syndrome using a new questionnaire tool. Rheumatology 43, 758\u2013764 (2004).","journal-title":"Rheumatology"},{"key":"1153_CR215","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr.","year":"1992","unstructured":"Ware, J. E. Jr. & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473\u2013483 (1992).","journal-title":"Med. Care"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01153-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01153-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01153-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:03:37Z","timestamp":1764248617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01153-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":215,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1038\/s41582-025-01153-z","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"29 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.-K.P. has received honoraria for speaking at scientific meetings, serving on scientific advisory boards and consulting activities from Adamas Pharma, Almirall, Bayer Pharma, Biogen, Celgene (Bristol-Myers Squibb), Sanofi-Genzyme, Janssen, Merck, Novartis, Roche and Teva; and has received research support from the German Multiple Sclerosis Society, Celgene, Novartis, Roche and Teva. M.G. has received honoraria for boards and speaking activities from Bayer, Biogen, Bristol-Myers Squibb, Johnson & Johnson, Merck, Novartis, Roche, Sanofi and Teva; and has received research support from the Bundesministerium f\u00fcr Bildung und Forschung, Deutsche Forschungsgemeinschaft, Merck and Sanofi. A.C. has received honoraria for boards and speaking activities from Alexion, Almirall, Biogen, Bristol-Myers Squibb, Genzyme, HorizonTherapeutics, Merck\u00a0KGaA, Novartis, Roche, Sanofi, Teva\u00a0and UCB, all for hospital research funds, and has received research support from Biogen, CSL Behring, Genzyme, Roche, UCB, the European Union and the Swiss National Research Foundation. He serves as an Associate Editor for the\n                      European Journal of Neurology\n                      and is on the editorial board of\n                      Clinical and Translational Neuroscience\n                      .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}